Cialis over the counter medicament – Eli Lilly’s steps towards making.

cialis-over-the-counterCialis is a medical remedy that relaxes the muscle tissue in certain parts of the body and increases blood current in these parts. It is successfully used for curing erection problems in males and removing prostate enlargement symptoms. This medicament is produced by Eli Lilly (American pharmaceutical giant). Another brand of this medicament is Adcirca. The latter is used for curing pulmonary arterial hypertension (increased blood pressure in lungs) both in male and female persons. According to studies, the patients suffering from this ailment after being treated with the medicament increased their six-minute walking distance by more than 30 meters in comparison with the group of patients taking placebo sugar tablets. Adcirca, as well as Cialis, is a prescription medical remedy.

Will Cialis be sold without doctor’s prescription?

In May 2014, the producer of Cialis (Eli Lilly) announced its plans to sell the medicament without a prescription after the patent protection expiration (in 2017). Thanks to this, men will not need to go to a healthcare professional before purchasing the medicament. Eli Lilly plans to enter into a contract with the French drug producing company Sanofi. According to statements made by representatives of Eli Lilly company, Sanofi will get the rights to manufacture and sell the medicament over the counter (OTC) in the European Union states, Canada, Australia and the US.

This step was caused by several factors. First, it will give the company an advantage over its competitors, (such drugs as Viagra and Levitra). Secondly, a lot of male persons do not consult a healthcare expert before buying anti-ED medical remedies. They are looking for cheaper variants on the Internet, thereby exposing themselves to danger, as many websites sell counterfeit medicines. By releasing OTC version of the medicament, pharmaceutical giants will fight against counterfeiting on the drug market.

However, it is not clear whether Cialis OTC approval will be got from the supervisory authorities of the countries where the drug is planned to be sold. In 2008, Pfizer abandoned similar intentions, as the EU Medicines Agency (European regulator responsible for the evaluation of medicinal remedies) expressed concerns about safety. US FDA should decide which clinical experiments solely responsible for the admission of OTC medicament on the market are to be conducted.

What is Sanofi?

Sanofi is French-based multinational pharmaceutical firm specializing in the development, manufacturing and promotion of medicaments of different kinds. It has more than 45 years of experience in the drug market. The headquarters of the firm is located in Gentilly, France. The firm has approximately 110,000 employees in one hundred countries around the world.
Sanofi’s development is based on seven growth platforms: emerging markets, vaccines for humans, drugs for diabetes, health products, innovative drugs, veterinary medicine and new Genzyme (a company that produces drugs saving the lives of people suffering from rare genetic ailments).